Skip Navigation


ToxSci Advance Access originally published online on November 10, 2006
Toxicological Sciences 2007 95(2):300-312; doi:10.1093/toxsci/kfl165
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Supplementary Data
Right arrow An erratum has been published
Right arrow All Versions of this Article:
95/2/300    most recent
kfl165v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (35)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Teeguarden, J. G.
Right arrow Articles by Pounds, J. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Teeguarden, J. G.
Right arrow Articles by Pounds, J. G.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Particokinetics In Vitro: Dosimetry Considerations for In Vitro Nanoparticle Toxicity Assessments

Justin G. Teeguarden1, Paul M. Hinderliter, Galya Orr, Brian D. Thrall and Joel G. Pounds

Pacific Northwest National Laboratory, Richland, Washington 99352

1 To whom correspondence should be addressed at Pacific Northwest National Laboratory, 902 Battelle Boulevard, Richland, WA 99352. Fax: (509) 376-9449 E-mail: justin.teeguarden{at}pnl.gov.

Received September 14, 2006; accepted October 27, 2006


  Abstract

The rapid growth in the use of in vitro methods for nanoparticle toxicity assessment has proceeded with limited consideration of the unique kinetics of these materials in solution. Particles in general and nanoparticles specifically, diffuse, settle, and agglomerate in cell culture media as a function of systemic and particle properties: media density and viscosity and particle size, shape, charge and density, for example. Cellular dose then is also a function of these factors as they determine the rate of transport of nanoparticles to cells in culture. Here we develop and apply the principles of dosimetry in vitro and outline an approach for simulation of nanoparticle particokinetics in cell culture systems. We illustrate that where equal mass concentrations (µg/ml) imply equal doses for dissimilar materials, the corresponding particle number or surface area concentration doses differ by orders of magnitude. More importantly, when rates of diffusional and gravitational particle delivery are accounted for, trends and magnitude of the cellular dose as a function of particle size and density differ significantly from those implied by "concentration" doses. For example, 15-nm silver nanoparticles appear ~4000 times more potent than micron-sized cadmium oxide particles on a cm2/ml media basis, but are only ~50 times more potent when differences in delivery to adherent cells are considered. We conclude that simple surrogates of dose can cause significant misinterpretation of response and uptake data for nanoparticles in vitro. Incorporating particokinetics and principles of dosimetry would significantly improve the basis for nanoparticle toxicity assessment, increasing the predictive power and scalability of such assays.

Key Words: nanomaterial; kinetics; dosimetry; in vitro; risk assessment; settling; agglomeration; diffusion.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 MutagenesisHome page
S.H. Doak, S.M. Griffiths, B. Manshian, N. Singh, P.M. Williams, A.P. Brown, and G.J.S. Jenkins
Confounding experimental considerations in nanogenotoxicology
Mutagenesis, July 1, 2009; 24(4): 285 - 293.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
K. M. Waters, L. M. Masiello, R. C. Zangar, B. J. Tarasevich, N. J. Karin, R. D. Quesenberry, S. Bandyopadhyay, J. G. Teeguarden, J. G. Pounds, and B. D. Thrall
Macrophage Responses to Silica Nanoparticles are Highly Conserved Across Particle Sizes
Toxicol. Sci., February 1, 2009; 107(2): 553 - 569.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
R. J. Griffitt, K. Hyndman, N. D. Denslow, and D. S. Barber
Comparison of Molecular and Histological Changes in Zebrafish Gills Exposed to Metallic Nanoparticles
Toxicol. Sci., February 1, 2009; 107(2): 404 - 415.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
D. Lison, L. C. J. Thomassen, V. Rabolli, L. Gonzalez, D. Napierska, J. W. Seo, M. Kirsch-Volders, P. Hoet, C. E. A. Kirschhock, and J. A. Martens
Nominal and Effective Dosimetry of Silica Nanoparticles in Cytotoxicity Assays
Toxicol. Sci., July 1, 2008; 104(1): 155 - 162.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
A. L. Holder, D. Lucas, R. Goth-Goldstein, and C. P. Koshland
Cellular Response to Diesel Exhaust Particles Strongly Depends on the Exposure Method
Toxicol. Sci., May 1, 2008; 103(1): 108 - 115.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
D. Dutta, S. K. Sundaram, J. G. Teeguarden, B. J. Riley, L. S. Fifield, J. M. Jacobs, S. R. Addleman, G. A. Kaysen, B. M. Moudgil, and T. J. Weber
Adsorbed Proteins Influence the Biological Activity and Molecular Targeting of Nanomaterials
Toxicol. Sci., November 1, 2007; 100(1): 303 - 315.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.